Fig. 3From: Shrinking lung syndrome treated with rituximab in pediatric systemic lupus erythematosus: a case report and review of the literaturePulmonary function tests (PFTs) over time in our patient with SLE and SLS; at diagnosis to 4 years following treatment with rituximab. FEV1, forced expiratory volume in 1 s; FVC, forced vital capacity; TLC, total lung capacity; RV, residual volumeBack to article page